{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:41:23Z","timestamp":1792590083812,"version":"4.5.0"},"reference-count":14,"publisher":"MyJove Corporation","issue":"230","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/69702","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:01:24Z","timestamp":1776812484000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluating Multimodal Functionality of Chimeric Antigen Receptor T Cells at Single-Cell Resolution through Optofluidics Analysis"],"prefix":"10.3791","author":[{"given":"Julia","family":"Franz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Freitag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodor","family":"Bormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hudecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maik","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"7897","key":"ref1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","type":"journal-article","article-title":"Decade-long leukaemia remissions with persistence of CD4+ CAR T cells","volume":"602","author":"Melenhorst","year":"2022","unstructured":"Melenhorst, J. J. et al. Decade-long leukaemia remissions with persistence of CD4+ CAR T cells. Nature. 602 (7897), 503-509 (2022).","journal-title":"Nature"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI85309","type":"journal-article","article-title":"CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients","volume":"126","author":"Turtle","year":"2016","unstructured":"Turtle, C. J. et al. CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients. J Clin Investigat. 126 (6), 2123-2138 (2016).","journal-title":"J Clin Investigat"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa2024850","type":"journal-article","article-title":"Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma","volume":"384","author":"Munshi","year":"2021","unstructured":"Munshi, N. C. et al. Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma. New Engl J Med. 384 (8), 705-716 (2021).","journal-title":"New Engl J Med"},{"issue":"15_suppl","key":"ref4","doi-asserted-by":"crossref","first-page":"8005","DOI":"10.1200\/JCO.2021.39.15_suppl.8005","type":"journal-article","article-title":"Ciltacabtagene autoleucel, a B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T-cell (CAR-T) therapy, in relapsed\/refractory multiple myeloma (R\/R MM): Updated results from CARTITUDE-1","volume":"39","author":"Usmani","year":"2021","unstructured":"Usmani, S. Z. et al. Ciltacabtagene autoleucel, a B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T-cell (CAR-T) therapy, in relapsed\/refractory multiple myeloma (R\/R MM): Updated results from CARTITUDE-1. J Clin Oncol. 39 (15_suppl), 8005 (2021).","journal-title":"J Clin Oncol"},{"issue":"8010","key":"ref5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41586-024-07242-1","type":"journal-article","article-title":"FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy","volume":"629","author":"Chan","year":"2024","unstructured":"Chan, J. D. et al. FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy. Nature. 629 (8010), 201-210 (2024).","journal-title":"Nature"},{"issue":"7786","key":"ref6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41586-019-1805-z","type":"journal-article","article-title":"c-Jun overexpression in CAR T cells induces exhaustion resistance","volume":"576","author":"Lynn","year":"2019","unstructured":"Lynn, R. C. et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 576 (7786), 293-300 (2019).","journal-title":"Nature"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","type":"journal-article","article-title":"Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","unstructured":"Fraietta, J. A. et al. Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat Med. 24 (5), 563-571 (2018).","journal-title":"Nat Med"},{"issue":"7709","key":"ref8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41586-018-0178-z","type":"journal-article","article-title":"Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells","volume":"558","author":"Fraietta","year":"2018","unstructured":"Fraietta, J. A. et al. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature. 558 (7709), 307-312 (2018).","journal-title":"Nature"},{"key":"ref9","type":"journal-article","article-title":"Metabolization of microbial postbiotic pentanoate drives anti-cancer CAR T cells","author":"Staudt","year":"2025","unstructured":"Staudt, S. et al. Metabolization of microbial postbiotic pentanoate drives anti-cancer CAR T cells. bioRxiv. 2024.08.19.608538, 10.1101\/2024.08.19.608538 (2025).","journal-title":"bioRxiv"},{"issue":"7906","key":"ref10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41586-022-04585-5","type":"journal-article","article-title":"T cell killing requires the IFN\u03b3R pathway in solid but not liquid tumours","volume":"604","author":"Larson","year":"2022","unstructured":"Larson, R. C. et al. CAR T cell killing requires the IFN\u03b3R pathway in solid but not liquid tumours. Nature. 604 (7906), 563-570 (2022).","journal-title":"Nature"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1038\/s41467-021-27613-w","type":"journal-article","article-title":"CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation","volume":"12","author":"Otano","year":"2021","unstructured":"Otano, I. et al. CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation. Nat Comm. 12 (1), 7296 (2021).","journal-title":"Nat Comm"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1182\/bloodadvances.2023012073","type":"journal-article","article-title":"Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma","volume":"8","author":"Denlinger","year":"2024","unstructured":"Denlinger, N. et al. Postinfusion PD-1+ CD8+ CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma. Blood Adv. 8 (12), 3140-3153 (2024).","journal-title":"Blood Adv"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.ymthe.2025.04.006","type":"journal-article","article-title":"High-dimensional temporal mapping of CAR T cells reveals phenotypic and functional remodeling during manufacturing","volume":"33","author":"Cadinanos-Garai","year":"2025","unstructured":"Cadinanos-Garai, A. et al. High-dimensional temporal mapping of CAR T cells reveals phenotypic and functional remodeling during manufacturing. Mol Ther J Am Soc Gene Ther. 33 (5), 2291-2309 (2025).","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1038\/s41467-024-46448-9","type":"journal-article","article-title":"Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus","volume":"15","author":"Doglio","year":"2024","unstructured":"Doglio, M. et al. Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus. Nat Comm. 15 (1), 2542 (2024).","journal-title":"Nat Comm"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/69702\/evaluating-multimodal-functionality-chimeric-antigen-receptor-t-cells","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:57:57Z","timestamp":1792587477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/69702\/evaluating-multimodal-functionality-chimeric-antigen-receptor-t-cells"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":14,"journal-issue":{"issue":"230","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/69702","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]}}}